Quarterly report [Sections 13 or 15(d)]

Share-Based Compensation (Tables)

v3.25.2
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Share Activity, Excluding Company's Employee Stock Purchase Plan
Number of
shares
Weighted
average
grant
date fair
value
Unvested at December 31, 2024 503,894  $ 8.55 
Granted 227,539  6.09 
Vested (95,335) 9.44 
Vested shares forgone to satisfy minimum statutory withholding (53,440) 9.44 
Forfeitures (71,444) 7.21 
Unvested at June 30, 2025 511,214  $ 7.39 
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
Weighted average grant date fair value of awards granted $ 5.91  $ 6.41  $ 6.09  $ 7.52 
Total fair value of shares vested $ 297,865  $ 112,198  $ 679,601  $ 747,525 
Total fair value of shares forgone to satisfy minimum statutory withholding $ 220,485  $ 92,150  $ 380,389  $ 464,343 
Schedule of Performance-Based Restricted Stock Units
Number of
shares
Weighted
average
grant
date fair
value
Unvested at December 31, 2024 189,221  $ 7.92 
Granted 364,905  5.70 
Forfeitures (121,324) 9.17 
Unvested at June 30, 2025 432,802  $ 5.70 
Three Months Ended June 30, Six Months Ended June 30,
2025 2024 2025 2024
Weighted average grant date fair value of awards granted $ 5.70  $ 5.69  $ 5.70  $ 5.69 
Total fair value of shares vested $ —  $ 83,862  $ —  $ 83,862 
Total fair value of shares forgone to satisfy minimum statutory withholding $ —  $ 67,137  $ —  $ 67,137 
Schedule of Share-based Payment Arrangement, Option, Activity
2014 Plan (Options) Number
of Authorized
Shares
Weighted-
Average Exercise
Price
Weighted-
Average
Remaining
Contractual Term (in Years)
Aggregate
Intrinsic Value
Outstanding at December 31, 2024 535,667  $ 7.00  3.57 $ 1,588,137 
Exercised (7,024) 2.60 
Exercised shares forgone to satisfy minimum statutory withholding (7,458) 2.60 
Shares tendered for cashless exercise (10,518) 2.60 
Forfeitures and expirations (50,750) 6.99 
Outstanding at June 30, 2025 459,917  $ 7.24  3.62 $ 789,568 
Exercisable at June 30, 2025 459,917  $ 7.24  3.62 $ 789,568 
2021 Plan (Options) Number
of Authorized
Shares
Weighted-
Average Exercise
Price
Weighted-
Average
Remaining
Contractual Term (in Years)
Aggregate
Intrinsic Value
Outstanding at December 31, 2024 1,840,786  $ 8.93  8.54 $ 1,504,894 
Granted 869,421  6.04 
Forfeitures and expirations (216,077) 6.96 
Outstanding at June 30, 2025 2,494,130  $ 8.10  8.61 $ 173,265 
Exercisable at June 30, 2025 (a) 1,117,523  $ 9.80  7.70 $ — 
(a) Aggregate Intrinsic Value - no exercisable options were in-the-money as of June 30, 2025.
Schedule of Share-based Compensation Expense Based on Fair Value of Options
The following is the average fair value per share estimated on the date of grant and the assumptions used for options granted:
Three Months Ended June 30, Six Months Ended June 30,
Stock Options: 2025 2024 2025 2024
Expected volatility
47% to 50%
46%
46% to 50%
46% to 51%
Risk free interest rate
3.87% to 3.98%
4.60%
3.87% to 4.01%
4.25% to 4.60%
Expected lives at date of grant (in years) 4.29 4.08 4.27 4.08
Weighted average fair value of options granted $2.78 $2.73 $2.73 $2.95
Total intrinsic value of options exercised $— $312,195 $89,500 $312,195